These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 19624783)
1. Optimising treatment for COPD--new strategies for combination therapy. Welte T Int J Clin Pract; 2009 Aug; 63(8):1136-49. PubMed ID: 19624783 [TBL] [Abstract][Full Text] [Related]
2. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease. Chen AM; Bollmeier SG; Finnegan PM Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624 [TBL] [Abstract][Full Text] [Related]
3. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Kew KM; Dias S; Cates CJ Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010844. PubMed ID: 24671923 [TBL] [Abstract][Full Text] [Related]
4. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Hanania NA Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761 [TBL] [Abstract][Full Text] [Related]
5. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? Reddy CB; Kanner RE Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532 [TBL] [Abstract][Full Text] [Related]
6. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Nannini LJ; Lasserson TJ; Poole P Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099 [TBL] [Abstract][Full Text] [Related]
7. The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Karner C; Cates CJ Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD009039. PubMed ID: 21901729 [TBL] [Abstract][Full Text] [Related]
8. Budesonide/formoterol Turbuhaler®: a review of its use in chronic obstructive pulmonary disease. Scott LJ Drugs; 2012 Feb; 72(3):395-414. PubMed ID: 22316354 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
10. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes. Hanania NA Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470 [TBL] [Abstract][Full Text] [Related]
11. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]
12. Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease? Tashkin DP Curr Opin Pulm Med; 2005 Mar; 11(2):121-8. PubMed ID: 15699783 [TBL] [Abstract][Full Text] [Related]
20. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Fuso L; Mores N; Valente S; Malerba M; Montuschi P Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]